Fenton Mary Kay bought CGEM
February 18, 2026 · Form 4 insider transaction
Fenton Mary Kay bought 68,750 shares of Cullinan Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
68,750
Price
$0.00
Total value
N/A
InsiderFenton Mary Kay
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2026
Filing dateFebruary 19, 2026
Shares owned after130,778
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the restricted stock unit vest on an annual basis over four years.